Michael Barbella

3 days ago | mpo-mag.com | Michael Barbella

Outset Medical Inc. has appointed Renee Gaeta as chief financial officer (CFO), succeeding Nabeel Ahmed. She will lead the company’s Finance and Information Technology and Human Resources departments. “Renee brings deep financial and leadership experience to Outset with a proven track record from her roles at publicly traded medical-device growth companies as both a CFO and board member,” Outset Medical Chair/CEO Leslie Trigg said.

3 days ago | mpo-mag.com | Michael Barbella

HistoSonics Inc. has completed patient enrollment in its pivotal #HOPE4KIDNEY trial, which aims to determine the safety and effectiveness of its Edison Histotripsy System in destroying kidney tumor tissue. The prospective, multi-site trial enrolled patients with a single, non-metastatic solid kidney mass ≤3 cm, confirmed by imaging and biopsy.

3 days ago | mpo-mag.com | Michael Barbella

Information Services Group (ISG) has launched a research study evaluating digital transformation service and solution providers supporting the medical devices industry, exploring the ways in which they help device makers address technological challenges while accelerating innovation and time to market.

3 days ago | mpo-mag.com | Michael Barbella

Foldax Inc. has secured Indian Central Drugs Standard Control Organization (CDSCO) approval for its TRIA Mitral Valve. Dolphin Life Science India LLP will manufacture the valve in India. “Gaining approval with our partner Dolphin Life Sciences for the world’s first polymer heart valve marks a defining moment in the evolution of heart valve therapy and disrupts long-standing paradigms in the heart valve industry,” Foldax CEO/Executive Chairman Ken Charhut said.

3 days ago | mpo-mag.com | Michael Barbella

Johnson & Johnson MedTech today launched the Polyphonic AI Fund for Surgery to help develop artificial intelligence (AI)-based solutions that solve challenges in surgery. Joined by a coalition of companies including NVIDIA and Amazon Web Services (AWS), the initiative augments Johnson & Johnson MedTech’s work to advance AI that will help redefine modern surgical practices and improve patient outcomes.